Collectively, these results suggest that the macrophage IL-10–STAT3 pathway could be a good target for therapies to block macrophage-promoted cyst expansion and thus to slow ADPKD disease progression. The gene discussed is STAT3; the disease is autosomal dominant polycystic kidney disease.